An Overlooked Long-Term Side Effect | Cancer Today
Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial - eClinicalMedicine
Cancers | Free Full-Text | Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy | HTML
Eloxatin: Dosage, side effects, price, alternatives, and more
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial - Annals of Oncology
Oxaliplatin - Wikipedia
Acute neurotoxic symptoms scored in patients receiving oxaliplatin | Download Table
Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study
Chronic oxaliplatin toxicity without sensory neuropathy. A–C : plots of... | Download Scientific Diagram
Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents - ScienceDirect
Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophylaxis is performed continuously
Oxaliplatin (Eloxatin) - Oncology Nurse Advisor
Effect of regulatory T-cell repletion on oxaliplatin-induced mechanical... | Download Scientific Diagram
Reintroduction of Oxaliplatin: A Viable Approach to the Long-Term Management of Metastatic Colorectal Cancer | Semantic Scholar
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity | SpringerLink
Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis
Oxaliplatin (Eloxatin) - Oncology Nurse Advisor
Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis
Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice | Scientific Reports
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text
Genome-wide single-nucleotide resolution of oxaliplatin–DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines - Journal of Biological Chemistry
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities - Cancer Treatment Reviews
